UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
______________________
Date of Report (Date of earliest event reported): December 11, 2017
OrthoPediatrics Corp. |
(Exact name of registrant as specified in its charter) |
Delaware |
(State or other jurisdiction of incorporation) |
001-38242 | 26-1761833 |
(Commission File Number) | (I.R.S. Employer Identification Number) |
2850 Frontier Drive Warsaw, Indiana | 46582 |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (574) 268-6379
Not Applicable |
(Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
[ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
[ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
[ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 under the Securities Act (17 CFR 230.405) or Rule 12b-2 under the Exchange Act (17 CFR 240.12b-2).
Emerging growth company [X]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act [X]
Item 7.01. Regulation FD Disclosure.
On December 11, 2017, OrthoPediatrics Corp. (“the Company”) issued a press release announcing the launch of the pediatric-specific Wrist Fusion Plate System. This plating system is the newest addition to the Company’s growing PediFrag franchise. A copy of the press release is furnished as Exhibit 99.1 to this Current Report.
The Company does not intend for this Item 7.01 or Exhibit 99.1 to be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
(d) | Exhibits | |
Exhibit No. | Description | |
* * * * * *
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
OrthoPediatrics Corp. | ||
Date: December 11, 2017 | By: | /s/ Daniel J. Gerritzen |
Daniel J. Gerritzen, General Counsel and Secretary | ||
- 2 -
FOR IMMEDIATE RELEASE
December 11, 2017
OrthoPediatrics Corp. Launches New Wrist Fusion Plate System
WARSAW, Indiana, December 11, 2017 — OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce the launch of its pediatric-specific Wrist Fusion Plate System. This plating system is the newest addition to the growing PediFrag franchise. The first of its kind, this project was designed in collaboration with the Sydney Children’s Hospital Network in Sydney, Australia with support from the Accelerating Commercialization Grant from the Australian Government. Pediatric Orthopedic Surgeon Professor David Little collaborated with OrthoPediatrics on the design of the system, and has been a great partner on several other co-development projects.
OrthoPediatrics’ Executive Vice President, David Bailey stated, “We are excited to introduce a new offering to the pediatric orthopedic market. In collaboration with our partners at Sydney Children’s Hospital, we couldn’t be prouder of the Wrist Fusion Plate System that we created together. It’s great to work with a team whose commitment to helping kids mirrors our own!”
The Wrist Fusion Plate System features plates in two implant length offerings to accommodate patients with, and without a proximal row carpectomy (PRC). Further, the stainless steel plates are low-profile to minimize plate prominence and reduce soft-tissue irritation.
Joe Hauser, OrthoPediatrics’ Vice President of Trauma & Deformity Correction explained the clinical significance of this offering for surgeons and patients, “When pediatric wrist deformities are too severe, ease of personal care, skin hygiene, hand function, and appearance can be adversely affected. For some neuromuscular patients, daily tasks like getting dressed can be difficult or even painful. Surgical intervention can improve the quality of life for many of these children. That’s why OrthoPediatrics designed the first ever pediatric specific plates for Wrist Fusion. This expanded offering provides our surgical partners a full suite of tools to treat children with orthopedic conditions.”
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is the only diversified orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market. OrthoPediatrics is dedicated to the cause of improving the lives of children with orthopedic conditions. OrthoPediatrics currently markets 23 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This offering spans trauma & deformity, complex spine and ACL reconstruction procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 35 countries outside the United States.
Investor Contact:
The Ruth Group, Tram Bui
(646) 536-7035
